TimeScale Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$34.7K Hold
74
0.01% 242
2023
Q1
$25.4K Sell
74
-35
-32% -$11.8K 0.01% 267
2022
Q4
$35.2K Hold
109
0.01% 182
2022
Q3
$35K Buy
109
+51
+88% +$16.2K 0.01% 183
2022
Q2
$19K Hold
58
0.01% 228
2022
Q1
$17K Buy
58
+28
+93% +$7.21K ﹤0.01% 250
2021
Q4
$8K Hold
30
﹤0.01% 330
2021
Q3
$7K Hold
30
﹤0.01% 348
2021
Q2
$7K Hold
30
﹤0.01% 355
2021
Q1
$6K Hold
30
﹤0.01% 363
2020
Q4
$5K Hold
30
﹤0.01% 335
2020
Q3
$4K Sell
30
-135
-82% -$20.9K ﹤0.01% 368
2020
Q2
$27K Buy
165
+100
+154% +$15.3K 0.01% 194
2020
Q1
$9K Sell
65
-1,306
-95% -$179K ﹤0.01% 285
2019
Q4
$180K Hold
1,371
0.05% 91
2019
Q3
$153K Buy
1,371
+65
+5% +$7.24K 0.05% 94
2019
Q2
$145K Buy
+1,306
New +$154K 0.05% 98

Other funds holding LLY

TimeScale Financial's LLY Position: Q2 2023 in Review

TimeScale Financial held its Eli Lilly (LLY) position steady in Q2 2023 at 74 shares worth $34.7K. The position accounts for 0.01% of the portfolio, ranked #242.

TimeScale Financial first reported a position in LLY in Q2 2019 and has held it in 17 quarters since. The position peaked at $180K in Q4 2019. 2,814 funds tracked by Wall St. Rank hold LLY as of Q2 2023.

  • TimeScale Financial held 74 shares of Eli Lilly worth $34.7K as of Q2 2023.
  • TimeScale Financial left its Eli Lilly share count unchanged in Q2 2023.
  • Eli Lilly made up 0.01% of TimeScale Financial's portfolio in Q2 2023, its #242 holding.
  • TimeScale Financial first reported a position in Eli Lilly in Q2 2019 and has held it in 17 quarters since.
  • TimeScale Financial's Eli Lilly position peaked at $180K in Q4 2019.
  • 2,814 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.